Public source

Reviewed 11 May 2026

Completeness Fair (28%)

Paige Breast Detect & Neoplasm

Paige

Paige Breast Detect & Neoplasm highlights foci suspicious for cancer and pre-cancerous neoplasms. For use with digitized H&E stained breast biopsy & excision images. It is the responsibility of a qualified pathologist to employ appropriate procedures to assure the quality of the images obtained and use manual visualization and re-evaluate the product’s results before incorporating in the final diagnosis. Results of the device shall only be considered after a professional pathologist’s initial review of the entire WSI.

Performance: Evaluated on a set of 2,303 breast biopsy & excision slides. Paige Breast has a specificity greater than 61% and sensitivity greater than 97% in identifying slides suspicious for cancer (includes: invasive carcinoma, ductal carcinoma in situ, lobular carcinoma in situ, atypical ductal hyperplasia, atypical lobular hyperplasia).

No papers to support — we monitor for new evidence.

General Information

Product name

Paige Breast Detect & Neoplasm

Company

Modality

Histopathology

Main task

Detection

Subspeciality

Breast pathology

Organ/Specimen source

Not specified

Disease targeted

Breast cancer

Specimen type

Biopsy, Excision

Staining

H&E

Stain subtype

Not specified

Regulatory Information

CE-IVD Certification

Pathway:

In Vitro Diagnostic Directive (IVDD)

Class:

General IVD Devices

Not verified by Health AI Register

Scanner Brands Certified for Use (CE-IVD)

Leica

Scanner Models Certified for Use (CE-IVD)

Not specified

Other certifications

Not specified

Evidence & Research

No research papers or evidence on file yet.

The registry monitors publications for new evidence.

Technical Specifications

Patient population age

Not specified

Input

Not specified

Input format

Not specified

Output

Not specified

Output format

Not specified

Integration

Not specified

Deployment

Not specified

Trigger for analysis

Not specified

Processing time

Not specified

Population

Not specified

Viewer systems

Not specified

Market Presence

On market since

Not specified

AI Platforms

Resellers

Not specified

Countries present

Not specified

Paying clinical customers

Not specified

Research/test users

Not specified

Pricing Information

Pricing model

Not specified

Based on

Not specified

Source: Public | First published: Aug 1, 2025 | Last updated: May 11, 2026

Paige Breast Detect & Neoplasm - Paige